MARATTO

article · Natural Product Research

Evaluation of antimycobacterial, antibacterial, and anticancer activities of new nodulisporacid derivatives isolated from endophytic fungus <i>Hypoxylon pulicicidum</i> using <i>in silico</i> studies

Abstract

had better binding energies with the AGNt protein, which also were greater than those of ciprofloxacin. To the best of our knowledge this is the first report presenting the antimycobacterial properties of each diasteroisomeric form of nodulisporacid derivative, proving that it is a potential antitubercular agent for further development in the pharmaceutical industry.

Research topics

  • Microbial Natural Products and Biosynthesis
  • Plant Disease Resistance and Genetics
  • Plant-Microbe Interactions and Immunity

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/14786419.2026.2654624

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.